Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 14, 2023
Harsh fiscal prospects and broader shifts in the health landscape are creating challenges for Gavi’s approach to country eligibility and transition. To date, Gavi’s income-based eligibility model has functioned well during periods of sustained growth in low- and middle-income countries and has helpe...
POLICY PAPERS
December 14, 2023
The prevailing fiscal outlook alongside broader shifts in the health landscape have important implications for countries’ eligibility for support from Gavi, the Vaccine Alliance. Current projections are similar to pre-COVID estimates, but the cohort of transitioning countries face more challenging ...
Blog Post
December 04, 2023
In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...
Blog Post
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
Blog Post
November 29, 2023
Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...
Blog Post
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...
Blog Post
November 08, 2023
How stable do emerging markets look now, in 2023? Which countries would be most and least resilient if another global adverse shock were to happen? A simple indicator constructed from a small set of economic and institutional variables was able to identify in 2019, prior to the COVID-19 pandemic and...
WORKING PAPERS
October 11, 2023
Many countries are facing a much harsher budgetary prospect than a few years ago. For low- and middle-income countries in particular, domestic health expenditure is expected to plateau or contract (in real terms) for many until 2027, development assistance for health has already plateaued, and a deb...
Blog Post
October 11, 2023
Prior to the COVID-19 pandemic there were periods of sustained growth in many low- and middle-income countries that led to some optimism about countries “transitioning” from (i.e. no longer being eligible for) support from the major global health financing mechanisms, such as the Global Fund, Gavi, ...
Blog Post
February 13, 2023
During this long period of leadership stability, there has been enormous growth in Gavi’s funding and staffing, even through the stormy waters of COVID-19, with enough vaccines delivered to legitimately claim millions of lives saved. Dr. Pate will arrive with a strong financial base, the ability to ...